Health Care [ 4/12 ] | Pharmaceuticals [ 26/74 ]
NASDAQ | Common Stock
Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company that develops and commercializes therapeutics and small molecule drugs for central nervous system (CNS), neuropsychiatric, and neurological disorders.
The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults.
It distributes its products through third-party wholesale drug distributors.
The company was founded in 2002 and is based in Bedminster, New Jersey.
As of April 2, 2025, Intra-Cellular Therapies, Inc. operates as a subsidiary of Johnson & Johnson Innovative Medicine.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 20, 25 | -0.16 Increased by +46.67% | -0.11 Decreased by -44.27% |
| Oct 30, 24 | -0.25 Increased by 0.00% | -0.20 Decreased by -25.00% |
| Aug 7, 24 | -0.16 Increased by +64.44% | -0.19 Increased by +15.79% |
| May 7, 24 | -0.16 Increased by +65.22% | -0.32 Increased by +50.00% |
| Feb 22, 24 | -0.30 Increased by +33.33% | -0.44 Increased by +31.82% |
| Nov 2, 23 | -0.25 Increased by +56.14% | -0.57 Increased by +56.14% |
| Aug 3, 23 | -0.45 Increased by +51.09% | -0.59 Increased by +23.73% |
| May 4, 23 | -0.46 Increased by +41.03% | -0.61 Increased by +24.59% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 199.22 M Increased by +51.49% | -16.89 M Increased by +40.92% | Decreased by -8.48% Increased by +61.00% |
| Sep 30, 24 | 175.16 M Increased by +39.23% | -26.32 M Decreased by -8.52% | Decreased by -15.03% Increased by +22.06% |
| Jun 30, 24 | 161.39 M Increased by +46.55% | -16.22 M Increased by +62.09% | Decreased by -10.05% Increased by +74.13% |
| Mar 31, 24 | 144.87 M Increased by +52.92% | -15.25 M Increased by +65.39% | Decreased by -10.52% Increased by +77.37% |
| Dec 31, 23 | 131.51 M Increased by +50.41% | -28.58 M Increased by +23.29% | Decreased by -21.73% Increased by +49.00% |
| Sep 30, 23 | 125.81 M Increased by +75.05% | -24.26 M Increased by +54.66% | Decreased by -19.28% Increased by +74.10% |
| Jun 30, 23 | 110.13 M Increased by +99.96% | -42.78 M Increased by +49.04% | Decreased by -38.85% Increased by +74.52% |
| Mar 31, 23 | 94.73 M Increased by +172.57% | -44.05 M Increased by +38.92% | Decreased by -46.50% Increased by +77.59% |